Studies using gene-targeting in mice have delineated the molecular framework of the mitochondria-dependent pathway of programmed cell death (PCD), 1 which has been conserved over species. While Bcl-X L , a CED-9 homologoue, prevents apoptosis, Apaf1, the mammalian homologue of CED-4, promotes cell death in the developing nervous system 2 ± 7 by activating caspases. 8 ± 11 Despite recent elucidation of the mitochondria-dependent pathway of apoptosis on molecule bases, it is as yet to be clarified whether these molecules exert their anti-and pro-apoptotic effects in the same linear fashion in different tissues during development.
To address this issue, we generated apaf1 and bcl-x double mutant mice and looked for rescue of phenotypes of respective single mutant mice. Bcl-X L -deficient (bcl-x 7/7 ) mice die around embryonic day (E) 13 with massive apoptosis of both brain cells and hematopoietic precursors in fetal liver. 2, 12 In contrast, Apaf1-deficient (apaf1 7/7 ) mice die at a later stage (E16.5 or later) with an accumulation of neurons in the brain. 6, 7 As shown in Table  1 , no apaf1 7/7 /bcl-x 7/7 mice were present among 215 live-born pups born to intercrosses between heterozygotes for the apaf1 and bcl-x mutations (apaf1 +/7 /bcl-x +/7 ). Furthermore, normal apaf1 7/7 /bcl-x 7/7 embryos were not observed beyond E13.5, indicating that apaf1 7/7 /bcl-x 7/7 embryos died around E13. Similarly, all bcl-x 7/7 embryos died by E13, but apaf1 7/7 embryos survived beyond this stage. Thus, all embryos lacking Bcl-X L (with or without Apaf1) died in utero by E13.5. These data show that deletion of apaf1 cannot rescue the embryonic lethal phenotype of Bcl-x deficiency.
The apaf1 7/7 embryos examined in this study showed morphological abnormalities at E12.5 and beyond that were consistent with previous reports. 6, 7 In particular, apaf1
embryos were subject to exencephalus ( Figure 1A ; K/W, arrowhead). Interestingly, apaf1 7/7 /bcl-x 7/7 embryos showed morphological abnormalities similar to those of apaf1 7/7 embryos, including exencephalus ( Figure 1A ; K/ K, arrowhead), while no such abnormalities were observed in any bcl-x 7/7 or wild-type embryos. Histological analyses revealed hyperplasia of the brain in both apaf1 7/7 and apaf1 7/7 /bcl-x 7/7 embryos ( Figure 1B ; K/W and K/K). Thickening of the cerebral cortex with supernumerary cells and narrowing of the ventricles were also observed in apaf1 7/7 embryos, phenotypes that were not rescued by mutation of the bcl-x gene. These data indicate that Apaf1 regulates the apoptosis of neurons in a pathway that operates independently of Bcl-X L .
To further examine the effects of Apaf1 and Bcl-x deficiency on the PCD of the developing brain, we performed TUNEL assays on brain tissue E12.5 wild-type and mutant embryos. In wild-type embryos, TUNEL-positive cells were observed in the hindbrain and dorsal root ganglia (DRG) ( Figure 1C ± E, W/W; 24+5.8 in the hindbrain and 57+29.0 in three DRG). In apaf1 7/7 embryos, far fewer TUNEL-positive cells were detected in the same regions ( Figure 1C ± E, K/W; 8.6+0.9 and 6+1.6 in the hindbrain and three DRG, respectively). In contrast to wild-type and apaf1 7/7 embryos, bcl-x
embryos showed a dramatic increase in TUNEL-positive cells in the intermediate zones of the ventral midbrain ( Figure 1C ; He/K; number not determined), in hindbrain ( Figure 1D ; 511.7+47.2) and in DRG ( Figure 1E ; 292.3+62.7). However, very few TUNEL-positive cells were detected in apaf1 7/7 /bclx 7/7 embryos, no more than in apaf1 7/7 embryos ( Figure  1C ± E, K/K; 9.6+1.9 and 7+1.8 in the hindbrain and three DRG, respectively). These results indicate that Apaf1 deficiency can counter the increased apoptosis of postmitotic immature neurons caused by Bcl-X L deficiency.
Although the most striking feature of apaf1 7/7 /bcl-x 7/7 embryos was their brain abnormality, these embryos died in utero around E13, just like Bcl-X L -deficient mice and considerably earlier than Apaf1-deficient mice. This result demonstrates that the lethality at E13 was conferred by Bclx L deficiency. We have previously reported that massive cell death takes place in immature hematopoietic cells of bcl-x 7/7 embryos, and that Bcl-X L is required for the prevention of apoptosis during the final stages of erythrogenesis. 2, 12 In apaf1 7/7 /bcl-x 7/7 embryos as well as in bcl-x 7/7 embryos, the liver was pale and appeared anemic (data not shown), suggesting that the hamatopoietic phenotype in the liver of bcl-x 7/7 embryos was not mitigated by mutation of apaf1. Histopathological analysis revealed scattered TUNEL-positive cells in wild-type fetal livers ( Figure 1F , W/W; 254.6+38.8 per field), reflecting the physiological PCD that occurs during the maturation of hematopoietic cells. As reported previously, 2 increased numbers of TUNEL-positive cells were detected in bcl-x 7/7 fetal liver ( Figure 1F , He/K; 1125+110.3 per field) compared to wild-type liver. In apaf1 7/7 /bcl-x 7/7 liver ( Figure 1F , K/K), the number of TUNEL-positive cells was significantly greater than in the wild-type and almost the same as that in bcl-x 7/7 liver (990+85.6 per field). In contrast, the number of TUNEL-positive cells in apaf1 Electron microscope examination of wild-type fetal liver revealed the presence of macrophages containing several condensed apoptotic nuclei ( Figure 1G ; W/W). These inclusions in macrophages reflect the process of terminal maturation and enucleation of erythrocytes. Greater numbers of macrophages with condensed nuclei were detected in bcl-x 7/7 liver ( Figure 1G ; He/K) compared to the wild-type (data not shown). Of note, in both bcl-x 7/7 and apaf1 7/7 /bcl-x 7/7 liver samples, many degenerated cells (in addition to condensed nuclei) were observed within macrophages ( Figure 1G, arrowheads) . This finding implies that the macrophages had phagocytosed other types of apoptotic cells (but did not physiologically enucleate them). In apaf1 7/7 /bcl-x 7/7 liver ( Figure 1G ; K/K), the condensed nuclei within macrophages were morphologically indistinguishable from those observed in bcl-x 7/7 liver. These results, together with the results of the TUNEL assays, indicated that Apaf1-mediated pathways play little, if any, role in physiological PCD during hematopoiesis in fetal liver. Moreover, Apaf1 does not appear to affect apoptotic events caused by Bcl-X L -deficiency in hematopoietic cells.
Our study of double mutant mice lacking both Apaf1 and Bcl-X L indicates that Apaf1 has a dominant role in regulating apoptosis in the developing brain, and that this role is independent of Bcl-X L . Roth et al. have described the effects of Bcl-X L and Casp3 double deficiency and have demonstrated that Casp3 mediates apoptosis of both founder and postmitotic neurons, while Bcl-X L regulates apoptosis in postmitotic neurons. 13 Considered in this light, our data strongly suggest that Apaf1 and the Apaf1-mediated pathway of apoptosis play a critical role in the execution of PCD in the developing brain. We have also demonstrated that the massive PCD of hematopoietic cells in fetal liver is entirely independent of Apaf1. Bcl-X L is required for the maintenance of hematopoietic precursors. 12 During the development of hematopoietic (erythroid) cells, nuclear condensation (and probably enucleation) is dependent on DNase II.
14 Signficantly, Bcl-X L -deficient embryos die by E13.5 whereas DNase II-deficient embryos survive until E17.5 or later, 14 demonstrating that Bcl-X L exerts its anti-apoptotic function before nuclear condensation dependent on DNase II takes place.
Studies in C. elegans have shown that molecules involved in PCD in this organism, CED-9, CED-4 and CED-3, function in a linear, epistatic manner. In mammals, however, our and others' data indicate that the mammalian counterparts of these apoptosis-related molecules, Bcl-2/ Bcl-X L , Apaf1 and caspases differentially regulate PCD depending on the tissue and/or stage of development/ differentiation. This difference may be accounted for by the fact that multiple family members of related function exist in mammals. 15, 16 Each of these family members could be uniquely involved in PCD in a different type of tissue or cell. In addition, mammals possess molecules not found in C. elegans, such as apoptosis-inducing factor (AIF) 17 and endonuclease G. 18 The complex web, in which all these players contribute to the regulation of mammalian PCD, and the issue of whether these molecules act independently of or interdependently with Bcl-X L and Apaf1 in mitochondria-mediated apoptosis, remain to be completely resolved. Our work offers the clarification that Apaf1 and Bcl-X L have distinct functions in regulating the development PCD of neurons and hematopoietic precursors. 
